Dexamethasone enhances osteoclast formation synergistically with transforming growth factor-beta by stimulating the priming of osteoclast progenitors for differentiation into osteoclasts. (Q52551676)

From Wikidata

Jump to navigation Jump to search

scientific article published on 27 August 2003

Language	Label	Description	Also known as
English	Dexamethasone enhances osteoclast formation synergistically with transforming growth factor-beta by stimulating the priming of osteoclast progenitors for differentiation into osteoclasts.	scientific article published on 27 August 2003

Statements

scholarly article

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/12944401

Dexamethasone enhances osteoclast formation synergistically with transforming growth factor-beta by stimulating the priming of osteoclast progenitors for differentiation into osteoclasts. (English)

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/12944401

1 reference

based on heuristic

inferred from title

author name string

Atsushi Takuma

1

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/12944401

Toshio Kaneda

2

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/12944401

Takuya Sato

3

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/12944401

Setsuo Ninomiya

4

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/12944401

Masayoshi Kumegawa

5

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/12944401

Yoshiyuki Hakeda

6

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/12944401

language of work or name

0 references

publication date

27 August 2003

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/12944401

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Journal of Biological Chemistry

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/12944401

278

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/12944401

45

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/12944401

44667-44674

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/12944401

Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

The pathobiology of the osteoclast

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Modulation of osteoclast differentiation by local factors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Distinct molecular mechanism for initiating TRAF6 signalling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Control of osteoclastogenesis and bone resorption by members of the TNF family of receptors and ligands

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Regulation of leukocyte-endothelial interactions by glucocorticoids.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Mechanisms of glucocorticoid action in bone

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Elevated 1,25-dihydroxyvitamin D levels in patients with chronic obstructive pulmonary disease treated with prednisone

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

A working hypothesis for the regulation of steroidogenesis and germ cell development in the gonads by glucocorticoids and 11 beta-hydroxysteroid dehydrogenase (11 beta HSD).

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Cortisol decreases bone formation by inhibiting periosteal cell proliferation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Glucocorticoids inhibit cell cycle progression in differentiating osteoblasts via glycogen synthase kinase-3beta

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Cross-talk between pro-inflammatory transcription factors and glucocorticoids.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Novel glucocorticoid receptor coactivator effector mechanisms

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Inhibition of alpha interferon but not gamma interferon signal transduction by phorbol esters is mediated by a tyrosine phosphatase

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Regional trabecular bone matrix degeneration and osteocyte death in femora of glucocorticoid- treated rabbits

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Effect of corticosteroids on human osteoclast formation and activity.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Negative regulation of nuclear factor-kappaB activation and function by glucocorticoids

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Convergence of TNFalpha and IFNgamma signalling pathways through synergistic induction of IRF-1/ISGF-2 is mediated by a composite GAS/kappaB promoter element

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Critical role of tumor necrosis factor-alpha and NF-kappa B in interferon-gamma -induced CD40 expression in microglia/macrophages

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Promoter structure of mouse RANKL/TRANCE/OPGL/ODF gene

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M300213200

21 January 2018

Identifiers

10.1074/JBC.M300213200

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/12944401

1 reference

Europe PubMed Central

3 May 2018

http://europepmc.org/abstract/MED/12944401

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52551676&oldid=1769681133"